Progyny Authorizes New $200M Share Repurchase Program
PGNY sits 60% above its 52-week low of $16.1.
Summary
Progyny's Board of Directors has approved a new share repurchase program of up to $200 million, signaling confidence in the company's valuation and commitment to shareholder returns.
Key Events · Financing and Capital Events · PGNY
-
New Share Repurchase Program Approved
The Board of Directors has authorized a new share repurchase program for up to $200 million of common stock.
-
Funded by Available Cash
The program will be funded through the company's available cash balances.
-
Flexible Execution
Shares may be repurchased through open market transactions, including Rule 10b5-1 plans, based on market conditions.
Analysis · PGNY · Industrial Applications And Services
Progyny's Board of Directors has authorized a new share repurchase program of up to $200 million. This is a significant capital allocation decision, representing over 10% of the company's current market capitalization. It follows the recent completion of a prior $200 million buyback program, indicating a continued strategy to return capital to shareholders and potentially enhance earnings per share. The authorization suggests management believes the stock is undervalued and aims to support its price.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 37.5% of the 3432 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PGNY was trading at $25.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $16.10 to $28.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.